We are a specialized pharmaceutical company in the advanced stages of clinical development, committed to the innovation and commercialization of cutting-edge nanomedicines. These utilize our unique lipid-based drug delivery platform in conjunction with approved active pharmaceutical ingredients (APIs). Our in-depth expertise in liposome technology enables us to enhance both the onset and duration of benefits, as well as optimize API concentrations in targeted tissues while reducing undesired systemic exposure.